Androgen deprivation therapy as backbone therapy in the management of prostate cancer

von Merseburger, Axel S, Alcaraz, Antonio, von Klot, Christoph A
Veröffentlicht in Onco Targets Ther (2016)

An update on enzalutamide in the treatment of prostate cancer

von Merseburger, Axel S., Haas, Gabriel P., von Klot, Christoph-A.
Veröffentlicht in Ther Adv Urol (2015)

Novel therapeutic options for second-line therapy in metastatic renal cell carcinoma

von VON KLOT, CHRISTOPH-A. J., MERSEBURGER, AXEL S., KUCZYK, MARKUS A.
Veröffentlicht in Mol Clin Oncol (2016)

Moderately HRT vs. CRT for localized prostate cancer using image-guided VMAT with SIB: evaluation of acute and late toxicities

von Vassis, Stratos, Nöldeke, Beatrice, Christiansen, Hans, von Klot, Christoph A., Merten, Roland
Veröffentlicht in Strahlenther Onkol (2020)

Efficacy of repeated PSMA PET-directed radiotherapy for oligorecurrent prostate cancer after initial curative therapy

von Henkenberens, Christoph, Oehus, Ann-Kathrin, Derlin, Thorsten, Bengel, Frank, Ross, Tobias L., Kuczyk, Markus A., Janssen, Stefan, Christiansen, Hans, von Klot, Christoph A. J.
Veröffentlicht in Strahlenther Onkol (2020)

DNA methylation of tumor associated calcium signal transducer 2 (TACSTD2) loci shows association with clinically aggressive renal cell cancers

von Katzendorn, Olga, Peters, Inga, Dubrowinskaja, Natalia, Tezval, Hossein, Tabrizi, Pouriya Faraj, von Klot, Christoph A., Hennenlotter, Jörg, Lafos, Marcel, Kuczyk, Markus A., Serth, Jürgen
Veröffentlicht in BMC Cancer (2021)

Role of free testosterone levels in patients with metastatic castration-resistant prostate cancer receiving second-line therapy

von von Klot, Christoph A., Kuczyk, Markus A., Boeker, Alena, Reuter, Christoph, Imkamp, Florian, Herrmann, Thomas R.W., Tezval, Hossein, Kramer, Mario W., Perner, Sven, Merseburger, Axel S.
Veröffentlicht in Oncol Lett (2017)

Galectin-1 and Galectin-3 mRNA expression in renal cell carcinoma

von von Klot, Christoph-A, Kramer, Mario W, Peters, Inga, Hennenlotter, Joerg, Abbas, Mahmoud, Scherer, Ralph, Herrmann, Thomas RW, Stenzl, Arnulf, Kuczyk, Markus A, Serth, Juergen, Merseburger, Axel S
Veröffentlicht 2014

Efficacy of PSMA PET-Guided Radiotherapy for Oligometastatic Castrate-Resistant Prostate Cancer

von Henkenberens, Christoph, Derlin, Thorsten, Bengel, Frank, Ross, Tobias L., Kuczyk, Markus A., Giordano, Frank A., Sarria, Gustavo R., Schmeel, Leonard Christopher, Christiansen, Hans, von Klot, Christoph A. J.
Veröffentlicht in Front Oncol (2021)

Impact of double J stenting or nephrostomy placement during transurethral resection of bladder tumour on the incidence of metachronous upper urinary tract urothelial cancer

von Hupe, Marie C., Dormayer, Lukas, Ozimek, Tomasz, Struck, Julian P., Hennig, Martin J. P., Klee, Melanie, von Klot, Christoph A. J., Kuczyk, Markus A., Merseburger, Axel S., Kramer, Mario W.
Veröffentlicht in BMC Cancer (2020)

Checkpoint Inhibition for Metastatic Urothelial Carcinoma After Chemotherapy—Real-World Clinical Impressions and Comparative Review of the Literature

von Fuhrmann, Christian, Struck, Julian P., Ivanyi, Philipp, Kramer, Mario W., Hupe, Marie C., Hensen, Bennet, Fürschke, Alexander, Peters, Inga, Merseburger, Axel S., Kuczyk, Markus A., von Klot, Christoph-A. J.
Veröffentlicht in Front Oncol (2020)

Bicentric Retrospective Analysis of en Bloc Resection and Muscularis Mucosae Detection Rate in Non-Muscle Invasive Bladder Tumors: A Real-World Scenario

von Struck, Julian P., Kramer, Mario W., Katzendorn, Olga, Hupe, Marie C., Ozimek, Tomasz, Hennig, Martin J. P., Wießmeyer, Judith R., von Klot, Christoph A. J., Kuczyk, Markus A., Kreipe, Hans H., Merseburger, Axel S., Perner, Sven, Dressler, Franz F.
Veröffentlicht in Adv Ther (2020)